IDXX: Innovation and recurring revenue growth drive higher diagnostic adoption and margin expansion
Strong Q2 performance and recurring revenue growth are fueling reinvestment in innovation and commercial expansion. Diagnostic utilization per visit is rising, driven by aging pets, breed trends, and new product launches. Commercial investments and AI-driven software support adoption, with internat…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.